| Primary |
| Drug Exposure During Pregnancy |
27.3% |
| Sepsis |
9.1% |
| Epilepsy |
7.3% |
| Abdominal Pain |
5.5% |
| Duodenal Ulcer |
5.5% |
| Maternal Therapy To Enhance Foetal Lung Maturity |
5.5% |
| Anal Fissure |
3.6% |
| Dental Discomfort |
3.6% |
| Infection |
3.6% |
| Liver Abscess |
3.6% |
| Pain |
3.6% |
| Pneumonia Aspiration |
3.6% |
| Pseudomembranous Colitis |
3.6% |
| Upper Respiratory Tract Infection |
3.6% |
| Anxiety |
1.8% |
| Cerebrovascular Accident |
1.8% |
| Diarrhoea |
1.8% |
| Irritable Bowel Syndrome |
1.8% |
| Pruritus |
1.8% |
| Psoriasis |
1.8% |
|
| Premature Baby |
11.1% |
| Electrocardiogram Qt Prolonged |
8.3% |
| Hallucination, Visual |
8.3% |
| Serum Sickness |
8.3% |
| Urticaria |
8.3% |
| Depressed Level Of Consciousness |
5.6% |
| International Normalised Ratio Increased |
5.6% |
| Pain |
5.6% |
| Visual Impairment |
5.6% |
| Vomiting |
5.6% |
| Anaphylactic Reaction |
2.8% |
| Blood Creatine Phosphokinase Increased |
2.8% |
| Clostridium Difficile Colitis |
2.8% |
| Diarrhoea |
2.8% |
| Dizziness |
2.8% |
| Hiccups |
2.8% |
| Medication Error |
2.8% |
| Myocardial Infarction |
2.8% |
| Pancytopenia |
2.8% |
| Paraesthesia |
2.8% |
|
| Secondary |
| Drug Use For Unknown Indication |
14.2% |
| Drug Therapy |
12.4% |
| Pain |
9.5% |
| Nutritional Support |
8.9% |
| Infection |
6.2% |
| Cardiac Failure |
5.0% |
| Abdominal Abscess |
4.7% |
| Intraoperative Care |
4.7% |
| Prophylaxis |
4.7% |
| Sepsis |
3.8% |
| Thrombosis Prophylaxis |
3.6% |
| Pseudomonas Infection |
3.3% |
| Inflammation |
2.7% |
| Analgesia |
2.4% |
| Exophthalmos |
2.4% |
| Gastrointestinal Disorder Therapy |
2.4% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.4% |
| Restlessness |
2.4% |
| Secretion Discharge |
2.4% |
| Diabetes Mellitus |
2.1% |
|
| Thermal Burn |
11.6% |
| Appendiceal Abscess |
9.3% |
| Vomiting |
9.3% |
| White Blood Cell Count Increased |
9.3% |
| Myocardial Infarction |
7.0% |
| Renal Failure Acute |
7.0% |
| Renal Tubular Acidosis |
7.0% |
| International Normalised Ratio Increased |
4.7% |
| Pseudomembranous Colitis |
4.7% |
| Sepsis |
4.7% |
| Urosepsis |
4.7% |
| Clostridium Difficile Colitis |
2.3% |
| Depressed Level Of Consciousness |
2.3% |
| Hiccups |
2.3% |
| Liver Function Test Abnormal |
2.3% |
| Medication Error |
2.3% |
| Myoglobinuria |
2.3% |
| Platelet Count Decreased |
2.3% |
| Proctitis |
2.3% |
| Pulmonary Fibrosis |
2.3% |
|
| Concomitant |
| Drug Use For Unknown Indication |
23.9% |
| Crohn's Disease |
15.0% |
| Hiv Infection |
8.5% |
| Pneumonia |
6.8% |
| Pain |
6.5% |
| Hypertension |
5.7% |
| Prophylaxis |
4.5% |
| Depression |
4.1% |
| Colorectal Cancer |
3.1% |
| Hepatitis C |
2.5% |
| Sepsis |
2.5% |
| Acute Myeloid Leukaemia |
2.0% |
| Enterococcal Infection |
2.0% |
| Anaemia Prophylaxis |
1.9% |
| Diarrhoea |
1.9% |
| Escherichia Infection |
1.9% |
| Germ Cell Cancer |
1.9% |
| Klebsiella Infection |
1.9% |
| Urinary Tract Infection |
1.9% |
| Sedation |
1.8% |
|
| Vomiting |
10.5% |
| Accidental Exposure |
7.5% |
| Death |
6.0% |
| Electrocardiogram Qt Prolonged |
6.0% |
| Thrombocytopenia |
6.0% |
| Pulmonary Embolism |
5.3% |
| Sepsis |
5.3% |
| Nephropathy Toxic |
4.5% |
| Pyrexia |
4.5% |
| Rhabdomyolysis |
4.5% |
| Squamous Cell Carcinoma |
4.5% |
| Tricuspid Valve Incompetence |
4.5% |
| Urinary Tract Infection |
4.5% |
| Weight Decreased |
4.5% |
| Hepatic Enzyme Increased |
3.8% |
| Neutropenia |
3.8% |
| Pitting Oedema |
3.8% |
| Stevens-johnson Syndrome |
3.8% |
| Toxic Epidermal Necrolysis |
3.8% |
| Systemic Inflammatory Response Syndrome |
3.0% |
|
| Interacting |
| Drug Use For Unknown Indication |
38.9% |
| Upper Respiratory Tract Infection |
16.7% |
| Sepsis |
11.1% |
| Arrhythmia |
8.3% |
| Cerebrovascular Accident |
8.3% |
| Helicobacter Infection |
8.3% |
| Epilepsy |
5.6% |
| Muscle Spasms |
2.8% |
|
| Upper Respiratory Tract Infection |
28.6% |
| Drug Interaction |
14.3% |
| International Normalised Ratio Increased |
14.3% |
| Nystagmus |
14.3% |
| Rash Macular |
14.3% |
| Throat Tightness |
14.3% |
|
